HUP0301330A3 - 2-aminocarbonyl-9h-purine derivatives - Google Patents

2-aminocarbonyl-9h-purine derivatives

Info

Publication number: HUP0301330A3
Authority: HU; Hungary
Prior art keywords: aminocarbonyl; purine derivatives; purine; derivatives
Prior art date: 2000-06-06

Application number

HU0301330A

Other languages

English (en)

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-06

Filing date

2001-06-05

Publication date

2005-02-28

2000-06-06 Priority claimed from GB0014048A external-priority patent/GB0014048D0/en

2000-10-11 Priority claimed from GB0024920A external-priority patent/GB0024920D0/en

2001-06-05 Application filed by Pfizer filed Critical Pfizer

2003-08-28 Publication of HUP0301330A2 publication Critical patent/HUP0301330A2/hu

2005-02-28 Publication of HUP0301330A3 publication Critical patent/HUP0301330A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Dermatology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Gynecology & Obstetrics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Psychiatry (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Communicable Diseases (AREA)

HU0301330A 2000-06-06 2001-06-05 2-aminocarbonyl-9h-purine derivatives HUP0301330A3 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0014048A GB0014048D0 (en)	2000-06-06	2000-06-06	Purine derivatives
GB0018246A GB0018246D0 (en)	2000-06-06	2000-07-25	Purine derivatives
GB0024920A GB0024920D0 (en)	2000-06-06	2000-10-11	Purine derivatives
PCT/IB2001/000973 WO2001094368A1 (en)	2000-06-06	2001-06-05	2-aminocarbonyl-9h-purine derivatives

Publications (2)

Publication Number	Publication Date
HUP0301330A2 HUP0301330A2 (hu)	2003-08-28
HUP0301330A3 true HUP0301330A3 (en)	2005-02-28

Family

ID=27255754

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0301330A HUP0301330A3 (en)	2000-06-06	2001-06-05	2-aminocarbonyl-9h-purine derivatives

Country Status (34)

Country	Link
EP (1)	EP1292604B1 (hu)
JP (2)	JP4129176B2 (hu)
KR (1)	KR100484704B1 (hu)
CN (1)	CN1249074C (hu)
AR (1)	AR030289A1 (hu)
AT (1)	ATE431356T1 (hu)
AU (2)	AU6053701A (hu)
BG (1)	BG107216A (hu)
BR (1)	BR0111263A (hu)
CA (1)	CA2414018C (hu)
CU (1)	CU23240B7 (hu)
CZ (1)	CZ20023875A3 (hu)
DE (1)	DE60138702D1 (hu)
DK (1)	DK1292604T3 (hu)
DZ (1)	DZ3439A1 (hu)
EA (1)	EA004983B1 (hu)
EE (1)	EE200200678A (hu)
ES (1)	ES2324816T3 (hu)
GC (1)	GC0000287A (hu)
HK (2)	HK1054042A1 (hu)
HR (1)	HRP20020960A2 (hu)
HU (1)	HUP0301330A3 (hu)
IL (2)	IL152783A0 (hu)
IS (1)	IS6599A (hu)
MA (1)	MA26910A1 (hu)
MX (1)	MXPA02012033A (hu)
NO (1)	NO324426B1 (hu)
NZ (1)	NZ522184A (hu)
OA (1)	OA12279A (hu)
PA (1)	PA8518801A1 (hu)
PL (1)	PL360435A1 (hu)
SK (1)	SK16752002A3 (hu)
TW (1)	TWI227240B (hu)
WO (1)	WO2001094368A1 (hu)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7378400B2 (en)	1999-02-01	2008-05-27	University Of Virginia Patent Foundation	Method to reduce an inflammatory response from arthritis
TWI227240B (en) *	2000-06-06	2005-02-01	Pfizer	2-aminocarbonyl-9H-purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
US20030013675A1 (en) *	2001-05-25	2003-01-16	Boehringer Ingelheim Pharma Kg	Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
EP1434782A2 (en)	2001-10-01	2004-07-07	University of Virginia Patent Foundation	2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
GB0129273D0 (en)	2001-12-06	2002-01-23	Pfizer Ltd	Crystalline drug form
US6974803B2 (en)	2001-12-06	2005-12-13	Pfizer Inc	Pharmaceutical combination
GB0129270D0 (en) *	2001-12-06	2002-01-23	Pfizer Ltd	Pharmaceutical combination
ATE381336T1 (de) *	2002-04-10	2008-01-15	Univ Virginia	Verwendung von a2a adenosin rezeptor agonisten und anti-pathogene mittel enthaltenden kombinationen zur behandlung von entzündungskrankheiten
US7067509B2 (en)	2003-03-07	2006-06-27	Neurocrine Biosciences, Inc.	Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
US20060178403A1 (en) *	2003-03-07	2006-08-10	Neurocrine Biosciences, Inc.	Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
TW200519106A (en)	2003-05-02	2005-06-16	Novartis Ag	Organic compounds
US7335648B2 (en)	2003-10-21	2008-02-26	Inspire Pharmaceuticals, Inc.	Non-nucleotide composition and method for inhibiting platelet aggregation
JP2007514647A (ja)	2003-10-21	2007-06-07	インスパイアーファーマシューティカルズ，インコーポレイティド	テトラヒドロ−フロ［３，４−ｄ］ジオキソール化合物並びに血小板凝集を阻害する組成物及び方法
US7749981B2 (en)	2003-10-21	2010-07-06	Inspire Pharmaceuticals, Inc.	Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
JP2007509180A (ja)	2003-10-21	2007-04-12	インスパイアーファーマシューティカルズ，インコーポレイティド	疼痛を治療するための、非ヌクレオチド組成物および方法
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
WO2006023272A1 (en)	2004-08-02	2006-03-02	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having a2a agonist activity
EP2266994B1 (en)	2004-08-02	2013-04-03	University Of Virginia Patent Foundation	2-propynyl adenosine analgos with modified 5'-ribose groups having A2A agonist activity
GT200500281A (es)	2004-10-22	2006-04-24	Novartis Ag	Compuestos organicos.
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
US7932376B2 (en)	2005-05-05	2011-04-26	Inspire Pharmaceuticals, Inc.	Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
KR20080049113A (ko)	2005-10-21	2008-06-03	노파르티스 아게	Ｉｌ-13에 대항한 인간 항체 및 치료적 용도
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
PT2322525E (pt)	2006-04-21	2013-12-26	Novartis Ag	Derivados de purina para utilização como agonistas do recetor de adenosina a2a
US20090286779A1 (en)	2006-09-29	2009-11-19	Novartis Ag	Pyrazolopyrimidines as lipid kinase inhibitors
EP2089393A1 (en)	2006-10-30	2009-08-19	Novartis AG	Heterocyclic compounds as antiinflammatory agents
US8431578B2 (en)	2008-01-11	2013-04-30	Novartis Ag	Organic compounds
CN102123990B (zh)	2008-06-19	2014-07-09	武田药品工业株式会社	杂环化合物及其用途
SI2391366T1 (sl)	2009-01-29	2013-01-31	Novartis Ag	Substituirani benzimidazoli za zdravljenje astrocitomov
CN102448978A (zh)	2009-05-29	2012-05-09	辉瑞有限公司	新颖的糖皮质激素受体激动剂
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
US8497368B2 (en)	2009-08-12	2013-07-30	Novartis Ag	Heterocyclic hydrazone compounds
ES2709108T3 (es)	2009-08-17	2019-04-15	Intellikine Llc	Compuestos heterocíclicos y usos de los mismos
EA201200318A1 (ru)	2009-08-20	2012-09-28	Новартис Аг	Гетероциклические оксимы
US8637516B2 (en)	2010-09-09	2014-01-28	Irm Llc	Compounds and compositions as TRK inhibitors
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
US20130324526A1 (en)	2011-02-10	2013-12-05	Novartis Ag	[1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
WO2012116237A2 (en)	2011-02-23	2012-08-30	Intellikine, Llc	Heterocyclic compounds and uses thereof
JP5959541B2 (ja)	2011-02-25	2016-08-02	ノバルティスアーゲー	Ｔｒｋ阻害剤としてのピラゾロ［１，５−ａ］ピリジン
EA026655B1 (ru)	2011-09-15	2017-05-31	Новартис Аг	6-ЗАМЕЩЕННЫЕ 3-(ХИНОЛИН-6-ИЛТИО)[1,2,4]ТРИАЗОЛО[4,3-a]ПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ c-MET ТИРОЗИНКИНАЗЫ
EP2793893A4 (en)	2011-11-23	2015-07-08	Intellikine Llc	IMPROVED TREATMENT REGIMES USING MTOR INHIBITORS
EP3964513A1 (en)	2012-04-03	2022-03-09	Novartis AG	Combination products with tyrosine kinase inhibitors and their use
JP2016512835A (ja)	2013-03-15	2016-05-09	インテリカイン，エルエルシー	キナーゼ阻害剤の組み合わせ及びそれらの使用
WO2015084804A1 (en)	2013-12-03	2015-06-11	Novartis Ag	Combination of mdm2 inhibitor and braf inhibitor and their use
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
US10195208B2 (en)	2014-07-31	2019-02-05	Novartis Ag	Combination therapy
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE331726T1 (de) *	1998-10-16	2006-07-15	Pfizer	Adenine-derivate
GB9913932D0 (en) *	1999-06-15	1999-08-18	Pfizer Ltd	Purine derivatives
TWI227240B (en) *	2000-06-06	2005-02-01	Pfizer	2-aminocarbonyl-9H-purine derivatives

2001
- 2001-05-31 TW TW090113146A patent/TWI227240B/zh not_active IP Right Cessation
- 2001-06-04 AR ARP010102656A patent/AR030289A1/es active IP Right Grant
- 2001-06-05 AU AU6053701A patent/AU6053701A/xx active Pending
- 2001-06-05 HU HU0301330A patent/HUP0301330A3/hu unknown
- 2001-06-05 AU AU2001260537A patent/AU2001260537B2/en not_active Ceased
- 2001-06-05 AT AT01934242T patent/ATE431356T1/de not_active IP Right Cessation
- 2001-06-05 IL IL15278301A patent/IL152783A0/xx active IP Right Grant
- 2001-06-05 CA CA002414018A patent/CA2414018C/en not_active Expired - Fee Related
- 2001-06-05 PL PL36043501A patent/PL360435A1/xx not_active Application Discontinuation
- 2001-06-05 ES ES01934242T patent/ES2324816T3/es not_active Expired - Lifetime
- 2001-06-05 MX MXPA02012033A patent/MXPA02012033A/es active IP Right Grant
- 2001-06-05 EP EP01934242A patent/EP1292604B1/en not_active Expired - Lifetime
- 2001-06-05 CN CNB018108024A patent/CN1249074C/zh not_active Expired - Fee Related
- 2001-06-05 DE DE60138702T patent/DE60138702D1/de not_active Expired - Lifetime
- 2001-06-05 NZ NZ522184A patent/NZ522184A/en unknown
- 2001-06-05 SK SK1675-2002A patent/SK16752002A3/sk unknown
- 2001-06-05 EE EEP200200678A patent/EE200200678A/xx unknown
- 2001-06-05 CZ CZ20023875A patent/CZ20023875A3/cs unknown
- 2001-06-05 EA EA200201179A patent/EA004983B1/ru not_active IP Right Cessation
- 2001-06-05 OA OA1200200363A patent/OA12279A/en unknown
- 2001-06-05 GC GCP20011415 patent/GC0000287A/en active
- 2001-06-05 DK DK01934242T patent/DK1292604T3/da active
- 2001-06-05 BR BR0111263-5A patent/BR0111263A/pt not_active IP Right Cessation
- 2001-06-05 DZ DZ013439A patent/DZ3439A1/fr active
- 2001-06-05 KR KR10-2002-7016606A patent/KR100484704B1/ko not_active IP Right Cessation
- 2001-06-05 WO PCT/IB2001/000973 patent/WO2001094368A1/en active Application Filing
- 2001-06-05 JP JP2002501916A patent/JP4129176B2/ja not_active Expired - Fee Related
- 2001-06-06 PA PA20018518801A patent/PA8518801A1/es unknown
2002
- 2002-10-23 BG BG107216A patent/BG107216A/bg unknown
- 2002-10-29 IS IS6599A patent/IS6599A/is unknown
- 2002-11-26 CU CU20020281A patent/CU23240B7/es not_active IP Right Cessation
- 2002-12-02 MA MA26930A patent/MA26910A1/fr unknown
- 2002-12-04 NO NO20025821A patent/NO324426B1/no not_active IP Right Cessation
- 2002-12-05 HR HR20020960A patent/HRP20020960A2/hr not_active Application Discontinuation
2003
- 2003-09-05 HK HK03106312A patent/HK1054042A1/xx not_active IP Right Cessation
2006
- 2006-09-05 HK HK06109837A patent/HK1089447A1/xx not_active IP Right Cessation
2007
- 2007-06-21 IL IL184144A patent/IL184144A/en not_active IP Right Cessation
2008
- 2008-01-15 JP JP2008005804A patent/JP2008150383A/ja active Pending

Also Published As

Publication number	Publication date
SK16752002A3 (sk)	2004-05-04
GC0000287A (en)	2006-11-01
CU23240B7 (es)	2007-10-17
DZ3439A1 (fr)	2001-12-13
PA8518801A1 (es)	2002-09-17
DK1292604T3 (da)	2009-06-15
DE60138702D1 (de)	2009-06-25
BG107216A (bg)	2003-05-30
EP1292604A1 (en)	2003-03-19
IS6599A (is)	2002-10-29
HRP20020960A2 (en)	2005-02-28
AR030289A1 (es)	2003-08-20
WO2001094368A1 (en)	2001-12-13
TWI227240B (en)	2005-02-01
HK1054042A1 (en)	2003-11-14
JP4129176B2 (ja)	2008-08-06
HK1089447A1 (en)	2006-12-01
BR0111263A (pt)	2003-06-17
PL360435A1 (en)	2004-09-06
ATE431356T1 (de)	2009-05-15
KR100484704B1 (ko)	2005-04-22
MXPA02012033A (es)	2003-04-25
NO20025821D0 (no)	2002-12-04
IL184144A (en)	2008-11-26
IL184144A0 (en)	2007-10-31
HUP0301330A2 (hu)	2003-08-28
CZ20023875A3 (cs)	2004-02-18
NZ522184A (en)	2004-05-28
KR20030032962A (ko)	2003-04-26
EE200200678A (et)	2004-06-15
CN1249074C (zh)	2006-04-05
EA200201179A1 (ru)	2003-04-24
AU6053701A (en)	2001-12-17
JP2003535871A (ja)	2003-12-02
CN1434830A (zh)	2003-08-06
IL152783A0 (en)	2003-06-24
AU2001260537B2 (en)	2006-05-25
MA26910A1 (fr)	2004-12-20
NO324426B1 (no)	2007-10-08
ES2324816T3 (es)	2009-08-17
NO20025821L (no)	2003-02-04
JP2008150383A (ja)	2008-07-03
EA004983B1 (ru)	2004-10-28
EP1292604B1 (en)	2009-05-13
CA2414018A1 (en)	2001-12-13
CA2414018C (en)	2007-10-16
OA12279A (en)	2003-01-01

Publication	Publication Date	Title
EG22695A (en)	2003-06-30	Novel phenyl-propargylether derivatives
HUP0301330A3 (en)	2005-02-28	2-aminocarbonyl-9h-purine derivatives
HRP20030055A2 (en)	2005-02-28	4-phenyl-pyridine derivatives
IL150841A0 (en)	2003-02-12	1h-imidazopyridine derivatives
DE60137350D1 (en)	2009-02-26	Bipolares ablationsgerät
IL155103A0 (en)	2003-10-31	Substituted c-cyclohexylmethylamine derivatives
HUP0300562A3 (en)	2006-02-28	Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the
IL155106A0 (en)	2003-10-31	Substituted 1-aminobutan-3-ol derivatives
IL150557A0 (en)	2003-02-12	Substituted aminomethyl-phenyl-cyclohexane derivatives
HK1052499A1 (zh)	2003-09-19	氨基磺酰基聯苯基衍生物
IL150558A0 (en)	2003-02-12	Aminomethyl-phenyl-cyclohexanone derivatives
IL155104A0 (en)	2003-10-31	5-amino-1-pentene-3-ol substituted derivatives
EP1408955A4 (en)	2006-09-06	NEW METALLOTEXAPHYRINE DERIVATIVES
IL151598A0 (en)	2003-04-10	2-phenylpyran-4-one derivatives
EP1311283A4 (en)	2004-09-01	OMEGA conopeptides
HK1054937A1 (en)	2003-12-19	1-Methylcarbapenem derivatives
GB0021639D0 (en)	2000-10-18	Maurotoxin derivatives
SI1246793T1 (en)	2005-06-30	Substituted aminomethyl-phenyl-cyclohexane derivatives
SI1322590T1 (sl)	2007-10-31	Substituirani 5-amino-1-penten-3-olni derivati
DE60140888D1 (en)	2010-02-04	Implantierbare gefässprothese
GB0004026D0 (en)	2000-04-12	Golfcart golftrolley
AU146069S (en)	2001-11-30	Beardtrimmer
GB0004220D0 (en)	2000-04-12	Netcheque

Legal Events

Date	Code	Title	Description
2009-12-28	FA9A	Lapse of provisional patent protection due to relinquishment or protection considered relinquished